Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04892017
Title A Phase 1/2 Study of DCC-3116 as Monotherapy and Combination Therapy in Patients With MAPK Pathway Mutant Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Deciphera Pharmaceuticals LLC
Indications

pancreatic ductal adenocarcinoma

colorectal cancer

Advanced Solid Tumor

melanoma

lung non-small cell carcinoma

Therapies

DCC-3116 + Sotorasib

Binimetinib + DCC-3116

DCC-3116

DCC-3116 + Trametinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST